Fluticasone propionate–loaded solid lipid nanoparticles with augmented anti-inflammatory activity: optimisation, characterisation and pharmacodynamic evaluation on rats

References

• Abaee, A., and Madadlou, A., 2016. Niosome-loaded cold-set whey protein hydrogels. Food chemistry, 196, 106–113.
   PubMed Web of Science ®Google Scholar
• Abdelbary, G., and El-Gendy, N., 2008. Niosome-encapsulated gentamicin for ophthalmic controlled delivery. AAPS PharmSciTech, 9 (3), 740–747.
   PubMed Web of Science ®Google Scholar
• Abdelkader, H., et al., 2011. Design and evaluation of controlled-release niosomes and discomes for naltrexone hydrochloride ocular delivery. Journal of pharmaceutical sciences, 100 (5), 1833–1846.
   PubMed Web of Science ®Google Scholar
• Ballanti, E., et al., 2013. Complement and autoimmunity. Immunologic research, 56 (2–3), 477–491.
   PubMed Web of Science ®Google Scholar
• Barua, S., and Mitragotri, S., 2014. Challenges associated with penetration of nanoparticles across cell and tissue barriers: A review of current status and future prospects. Nano today, 9 (2), 223–243.
   PubMed Web of Science ®Google Scholar
• Bibi, S., et al., 2012. Trigger release liposome systems: local and remote controlled delivery? Journal of microencapsulation, 29 (3), 262–276.
   PubMed Web of Science ®Google Scholar
• Bleehen, S.S., et al., 1995. Fluticasone propionate 0.05% cream in the treatment of atopic eczema: a multicentre study comparing once-daily treatment and once-daily vehicle cream application versus twice-daily treatment. The british journal of dermatology, 133 (4), 592–597.
   PubMed Web of Science ®Google Scholar
• Bnyan, R., et al., 2018. Surfactant effects on lipid-based vesicles properties. Journal of pharmaceutical sciences, 107 (5), 1237–1246.
   PubMed Web of Science ®Google Scholar
• Cavalli, R., et al., 1999. Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with β-cyclodextrins. International journal of pharmaceutics, 182 (1), 59–69.
   PubMed Web of Science ®Google Scholar
• Dainichi, T., Hanakawa, S., and Kabashima, K., 2014. Classification of inflammatory skin diseases: a proposal based on the disorders of the three-layered defense systems, barrier, innate immunity and acquired immunity. Journal of dermatological science, 76 (2), 81–89.
   PubMed Web of Science ®Google Scholar
• Danhier, F., et al., 2009. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation. Journal of controlled release: official journal of the controlled release society, 133 (1), 11–17.
   PubMed Web of Science ®Google Scholar
• Dianzani, C., et al., 2017. Solid lipid nanoparticles delivering anti-inflammatory drugs to treat inflammatory bowel disease: effects in an in vivo model. World journal of gastroenterology, 23 (23), 4200–4210.
   PubMed Web of Science ®Google Scholar
• Doktorovová, S., et al., 2010. Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC). Colloids and surfaces. B, biointerfaces, 75 (2), 538–542.
   PubMed Web of Science ®Google Scholar
• El-Gendy, N., Pornputtapitak, W., and Berkland, C., 2011. Nanoparticle agglomerates of fluticasone propionate in combination with albuterol sulfate as dry powder aerosols. European journal of pharmaceutical sciences: official journal of the European federation for pharmaceutical sciences, 44 (4), 522–533.
   PubMed Web of Science ®Google Scholar
• El-Ridy, M.S., et al., 2011. Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin. Drug development and industrial pharmacy, 37 (12), 1491–1508.
   PubMed Web of Science ®Google Scholar
• El-Say, K.M., et al., 2016. Diacerein niosomal gel for topical delivery: development, in vitro and in vivo assessment. Journal of liposome research, 26 (1), 57–68.
   PubMed Web of Science ®Google Scholar
• El-Say, K.M., et al., 2015. Statistical optimization of controlled release microspheres containing cetirizine hydrochloride as a model for water soluble drugs. Pharmaceutical development and technology, 20 (6), 738–746.
   PubMed Web of Science ®Google Scholar
• Garcês, A., et al., 2018. Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: a review. European journal of pharmaceutical sciences: official journal of the European federation for pharmaceutical sciences, 112, 159–167.
   PubMed Web of Science ®Google Scholar
• González-Mira, E., et al., 2011. Potential use of nanostructured lipid carriers for topical delivery of flurbiprofen. Journal of pharmaceutical sciences, 100 (1), 242–251.
   PubMed Web of Science ®Google Scholar
• Guinedi, A.S., et al., 2005. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. International journal of pharmaceutics, 306 (1–2), 71–82.
   PubMed Web of Science ®Google Scholar
• Haider, M., et al., 2020. Nanostructured lipid carriers for delivery of chemotherapeutics: a review. Pharmaceutics, 12 (3), 288.
   Web of Science ®Google Scholar
• Harbi, I., et al., 2016. Glycosylated sertraline-loaded liposomes for brain targeting: QbD study of formulation variabilities and brain transport. AAPS PharmSciTech, 17 (6), 1404–1420.
   PubMed Web of Science ®Google Scholar
• Jana, U., et al., 2014. Felodipine loaded PLGA nanoparticles: preparation, physicochemical characterization and in vivo toxicity study. Nano convergence., 1 (1), 31.
   Google Scholar
• Javed, I., et al., 2015. Synthesis, characterization and evaluation of lecithin-based nanocarriers for the enhanced pharmacological and oral pharmacokinetic profile of amphotericin B. Journal of materials chemistry B, 3 (42), 8359–8365.
   PubMed Web of Science ®Google Scholar
• Javed, I., et al., 2016. Lecithin-gold hybrid nanocarriers as efficient and pH selective vehicles for oral delivery of diacerein-in-vitro and in-vivo study. Colloids and surfaces B, biointerfaces, 141, 1–9.
   PubMed Web of Science ®Google Scholar
• Kalinski, P., 2012. Regulation of immune responses by prostaglandin E2. Journal of immunology, 188 (1), 21–28.
   PubMed Web of Science ®Google Scholar
• Kapoor, B., et al., 2019. The why, where, who, how, and what of the vesicular delivery systems. Advances in colloid and interface science, 271, 101985.
   PubMed Web of Science ®Google Scholar
• Kassem, M.A., et al., 2017. Maximizing the therapeutic efficacy of imatinib mesylate-loaded niosomes on human colon adenocarcinoma using Box-Behnken design. Journal of pharmaceutical sciences, 106 (1), 111–122.
   PubMed Web of Science ®Google Scholar
• Kumar, S., et al., 2015. Biocompatible PLGA-oil hybrid nanoparticles for high loading and controlled delivery of resveratrol. Journal of drug delivery science and technology, 30, 54–62.
   Web of Science ®Google Scholar
• Kumar, G.P., and Rajeshwarrao, P., 2011. Nonionic surfactant vesicular systems for effective drug delivery—an overview. Acta pharmaceutica sinica B, 1 (4), 208–219.
   Web of Science ®Google Scholar
• Leung, D.Y.M., 2000. Atopic dermatitis: New insights and opportunities for therapeutic intervention. The journal of allergy and clinical immunology, 105 (5), 860–876.
   PubMed Web of Science ®Google Scholar
• Mahale, N.B., et al., 2012. Niosomes: Novel sustained release nonionic stable vesicular systems-an overview. Advances in colloid and interface science, 183–184, 46–54.
   PubMed Web of Science ®Google Scholar
• Mahmoudi Najafi, S.H., Baghaie, M., and Ashori, A., 2016. Preparation and characterization of acetylated starch nanoparticles as drug carrier: ciprofloxacin as a model. International journal of biological macromolecules, 87, 48–54.
   PubMed Web of Science ®Google Scholar
• Marianecci, C., et al., 2010. Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: Characterization and interaction with human lung fibroblasts. Journal of controlled release, 147 (1), 127–135.
   PubMed Web of Science ®Google Scholar
• Marianecci, C., et al., 2012. Anti-inflammatory activity of novel ammonium glycyrrhizinate/niosomes delivery system: human and murine models. Journal of controlled release: official journal of the controlled release society, 164 (1), 17–25.
   PubMed Web of Science ®Google Scholar
• Marianecci, C., et al., 2014. Niosomes from 80s to present: The state of the art. Advances in colloid and interface science, 205, 187–206.
   PubMed Web of Science ®Google Scholar
• Marianecci, C., et al., 2014. Ammonium glycyrrhizinate-loaded niosomes as a potential nanotherapeutic system for anti-inflammatory activity in murine models. International journal of nanomedicine, 9, 635–651.
   PubMed Web of Science ®Google Scholar
• Mehta, S.K., and Jindal, N., 2013. Formulation of tyloxapol niosomes for encapsulation, stabilization and dissolution of anti-tubercular drugs. Colloids and surfaces B, biointerfaces, 101, 434–441.
   PubMed Web of Science ®Google Scholar
• Michael, Y., et al., 2000. The physico-chemical properties of salmeterol and fluticasone propionate in different solvent environments. International journal of pharmaceutics, 200 (2), 279–288.
   PubMed Web of Science ®Google Scholar
• Montenegro, L., et al., 2016. From nanoemulsions to nanostructured lipid carriers: A relevant development in dermal delivery of drugs and cosmetics. Journal of drug delivery science and technology, 32, 100–112.
   Web of Science ®Google Scholar
• Mudshinge, S.R., et al., 2011. Nanoparticles: Emerging carriers for drug delivery. Saudi pharmaceutical journal: SPJ: the official publication of the Saudi Pharmaceutical Society, 19 (3), 129–141.
   PubMed Web of Science ®Google Scholar
• Mujtaba, A., Ali, M., and Kohli, K., 2014. Statistical optimization and characterization of pH-independent extended-release drug delivery of cefpodoxime proxetil using Box-Behnken design. Chemical engineering research and design, 92 (1), 156–165.
   Web of Science ®Google Scholar
• Mulik, R.S., et al., 2012. ApoE3 mediated polymeric nanoparticles containing curcumin: Apoptosis induced in vitro anticancer activity against neuroblastoma cells. International journal of pharmaceutics, 437 (1-2), 29–41.
   PubMed Web of Science ®Google Scholar
• Parameswaran, N., and Patial, S., 2010. Tumor necrosis factor-α signaling in macrophages. Critical reviews in eukaryotic gene expression, 20 (2), 87–103.
   PubMed Web of Science ®Google Scholar
• Patel, D., et al., 2012. Nanostructured lipid carriers (NLC)-based gel for the topical delivery of aceclofenac: preparation, characterization, and in vivo evaluation. Scientia pharmaceutica, 80 (3), 749–764.
   PubMedGoogle Scholar
• Pramod, K., et al., 2015. Unveiling the compatibility of eugenol with formulation excipients by systematic drug-excipient compatibility studies. Journal of analytical science and technology, 6, 34.
   Google Scholar
• Qushawy, M., et al., 2019. Preparation and evaluation of carbamazepine solid lipid nanoparticle for alleviating seizure activity in pentylenetetrazole-kindled mice. Molecules, 24 (21), 3971.
   Web of Science ®Google Scholar
• Ruckmani, K., and Sankar, V., 2010. Formulation and optimization of zidovudine niosomes. AAPS PharmSciTech, 11 (3), 1119–1127.
   PubMed Web of Science ®Google Scholar
• Sabzevari, A., et al., 2013. Polymeric triamcinolone acetonide nanoparticles as a new alternative in the treatment of uveitis: in vitro and in vivo studies. European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 84 (1), 63–71.
   PubMed Web of Science ®Google Scholar
• Sahoo, R.K., et al., 2014. Development and in vitro/in vivo evaluation of controlled release provesicles of a nateglinide – maltodextrin complex. Acta pharmaceutica sinica B, 4 (5), 408–416.
   PubMed Web of Science ®Google Scholar
• Sala, M., et al., 2018. Lipid nanocarriers as skin drug delivery systems: properties, mechanisms of skin interactions and medical applications. International journal of pharmaceutics, 535 (1-2), 1–17.
   PubMed Web of Science ®Google Scholar
• Sarkhel, S., 2016. Evaluation of the anti-inflammatory activities of Quillaja saponaria Mol. saponin extract in mice. Toxicology reports, 3, 1–3.
   PubMed Web of Science ®Google Scholar
• Shenoy, V.S., Gude, R.P., and Murthy, R.S., 2013. In vitro anticancer evaluation of 5-fluorouracil lipid nanoparticles using B16F10 melanoma cell lines. International nano letters, 3 (1), 36.
   Google Scholar
• Silva, C.O., et al., 2015. Polymeric nanoparticles modified with fatty acids encapsulating betamethasone for anti-inflammatory treatment. International journal of pharmaceutics, 493 (1–2), 271–284.
   PubMed Web of Science ®Google Scholar
• Soliman, M.S., et al., 2018. Date seed oil loaded niosomes: development, optimization and anti-inflammatory effect evaluation on rats. Drug development and industrial pharmacy, 44 (7), 1185–1197.
   PubMed Web of Science ®Google Scholar
• Soulele, K., et al., 2015. Population pharmacokinetics of fluticasone propionate/salmeterol using two different dry powder inhalers. European journal of pharmaceutical sciences: official journal of the European federation for pharmaceutical sciences, 80, 33–42.
   PubMed Web of Science ®Google Scholar
• Takeuchi, O., and Akira, S., 2010. Pattern recognition receptors and inflammation. Cell, 140 (6), 805–820.
   PubMed Web of Science ®Google Scholar
• Tatiya, A.U., et al., 2017. Evaluation of analgesic and anti-inflammatory activity of Bridelia retusa (Spreng) bark. Journal of traditional and complementary medicine, 7 (4), 441–451.
   PubMedGoogle Scholar
• Turvey, S.E., and Broide, D.H., 2010. Innate immunity. The journal of allergy and clinical immunology, 125 (2 Suppl 2), S24–S32.
   PubMed Web of Science ®Google Scholar
• Vogt, A., et al., 2016. Nanocarriers for drug delivery into and through the skin - Do existing technologies match clinical challenges? Journal of controlled release: official journal of the controlled release society, 242, 3–15.
   PubMed Web of Science ®Google Scholar
• Wilczewska, A., et al., 2012. Nanoparticles as drug delivery systems. Pharmacological reports: PR, 64 (5), 1020–1037.
   PubMed Web of Science ®Google Scholar
• Winter, C.A., Risley, E.A., and Nuss, G.W., 1962. Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs. Proceedings of the society for experimental biology and medicine. Society for experimental biology and medicine, 111 (3), 544–547.
   PubMed Web of Science ®Google Scholar
• Xu, Z., et al., 2010. Dry powder aerosols generated by standardized entrainment tubes from drug blends with lactose monohydrate: 2. Ipratropium bromide monohydrate and fluticasone propionate. Journal of pharmaceutical sciences, 99 (8), 3415–3429.
   PubMed Web of Science ®Google Scholar
• Yuksel, N., et al., 2016. In situ niosome forming maltodextrin proniosomes of candesartan cilexetil: in vitro and in vivo evaluations. International journal of biological macromolecules, 82, 453–463.
   PubMed Web of Science ®Google Scholar